Brown & Brown (BRO)
NYSEFinancialsInsurance - BrokersSnapshot 2026-09-04
$71.42-1.57%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - BrokersSnapshot 2026-09-04
QuarterlyIQ Insights · BRO
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within financials on a research-validated quality screen. As of 2026-09-04.
The screen ranks BRO against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 3 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Financials names rated neutral grew net income 55% of the time over the next year (vs 62% for the rest of the cohort, n=10246).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Met or beat guidance 100% of the last 1 guided quarters · 0.0% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on growing Organic Revenue including contingent commissions as a key growth metric.
Stated as a priority in 8 of last 8 quarters. Organic Revenue with Contingents grew 0.7% in 2026-Q2 and 2.2% in 2026-Q1, with prior quarters showing mixed but generally positive growth trends. Management consistently emphasizes this growth metric, and the trajectory shows mixed delivery with modest recent growth.
“Organic Revenue with Contingents increasing 0.7%”
“Organic Revenue with Contingents increasing 2.2%”
“Organic Revenue decreasing 2.8%”
“Organic Revenue growth of 3.5%”
“Organic Revenue growth of 3.6%”
“Organic Revenue increasing by 6.5%”
“Organic Revenue increasing by 13.8%”
“Organic Revenue increasing by 9.5%”
Focus on improving adjusted diluted net income per share as a key profitability metric.
Stated as a priority in 8 of last 8 quarters. Adjusted diluted net income per share increased from $1.03 in 2025-Q2 to $1.07 in 2026-Q2 and from $1.29 in 2025-Q1 to $1.39 in 2026-Q1. Management consistently highlights earnings growth and momentum, indicating delivery on this priority.
Sustain or improve EBITDAC Margin - Adjusted as a measure of operational efficiency and profitability.
Stated as a priority in 8 of last 8 quarters. EBITDAC Margin - Adjusted was 35.7% in 2026-Q2, slightly down from 36.7% in 2025-Q2, and 38.5% in 2026-Q1, slightly up from 38.1% in 2025-Q1. Management emphasizes margin maintenance and expansion, with mixed but generally stable delivery.
Over the trailing year it converted 0.60x of net income into operating cash flow. Historically, Financials names rated fragile grew net income 52% of the time over the next year (vs 61% for the rest of the cohort, n=6844).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
18 material management or governance events in the past 24 months, led by executive changes. Historically, Financials names rated neutral grew net income 56% of the time over the next year (vs 58% for the rest of the cohort, n=3751).
Not investment advice. As of 2026-09-04.
“Diluted Net Income Per Share - Adjusted increasing to $1.07”
“Diluted Net Income Per Share - Adjusted increasing to $1.39”
“Diluted Net Income Per Share - Adjusted increasing to $0.93”
“Diluted Net Income Per Share - Adjusted increasing to $1.05”
“Diluted Net Income Per Share - Adjusted increasing to $1.03”
“Diluted Net Income Per Share - Adjusted increasing to $1.29”
“Diluted Net Income Per Share - Adjusted increasing to $0.86”
“Diluted Net Income Per Share - Adjusted increasing to $0.91”
“EBITDAC Margin - Adjusted of 35.7%”
“EBITDAC Margin - Adjusted of 38.5%”
“EBITDAC Margin - Adjusted of 32.9%”
“EBITDAC Margin - Adjusted of 36.6%”
“EBITDAC Margin - Adjusted of 36.7%”
“EBITDAC Margin - Adjusted of 38.1%”
“EBITDAC Margin - Adjusted of 32.9%”
“EBITDAC Margin - Adjusted of 34.9%”